Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.70 |
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.59 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.59 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | CDC25A | P30304 | 1/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.47 |
| ▸ | AKT1 | P31749 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1725069 | 1.00 | CYP3A4 (0.70) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL3818750 | 1.00 | CYP3A4 (0.70) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL3814014 | 1.00 | CYP3A4 (0.70) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL7870764 | 1.00 | CYP3A4 (0.70) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL3820824 | 1.00 | CYP3A4 (0.70) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL3814693 | 1.00 | CYP3A4 (0.70) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL536943 | 1.00 | CYP3A4 (0.70) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL3816327 | 1.00 | CYP3A4 (0.70) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL22844591 | 1.00 | CYP3A4 (0.70) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL28615636 | 1.00 | CYP3A4 (0.70) | CYP3A4LPAR3LPAR2LPAR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8017562-B2 | Gelled hydrocarbons for oilfield processes, phosphate ester compounds useful in gellation of hydrocarbons and methods for production and use thereof | BRINE-ADD FLUIDS LTD. (CA) | 2011-09-13 | — | — | US | disclosed |
| US-7972996-B2 | Gelled hydrocarbons for oilfield processes, phosphate ester compounds useful in gellation of hydrocarbons and methods for production and use thereof | Brine-Add Fluids Ltd (CA) | 2011-07-05 | — | — | US | disclosed |
| US-7947632-B2 | Gelled hydrocarbons for oilfield processes, phosphate ester compounds useful in gellation of hydrocarbons and methods for production and use thereof | BRINE-ADD FLUIDS LTD. (CA) | 2011-05-24 | — | — | US | disclosed |
| US-20110100633-A1 | GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF | BRINE-ADD FLUIDS LTD. (CA) | 2011-05-05 | — | — | US | disclosed |
| US-20110046408-A1 | GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF | BRINE-ADD FLUIDS LTD. (CA) | 2011-02-24 | — | — | US | disclosed |
| US-20090203556-A1 | GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF | BRINE-ADD FLUIDS LTD. (CA) | 2009-08-13 | — | — | US | disclosed |
| CN-1210093-C | Composite film and method for producing same | DOW GLOBAL TECHNOLOGY CO (US) | 2005-07-13 | — | — | CN | disclosed |
| CN-1441693-A | Composite film and method for producing same | DOW GLOBAL TECHNOLOGY CO (US) | 2003-09-10 | — | — | CN | disclosed |
| US-4117022-A | NICKEL BIS-DIORGANO-ORTHOPHOSPHATES THEIR PREPARATION AND USE | ANDERSON DEVELOPMENT COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
| US-4111839-A | NICKEL BIS-ORGANO-ORTHOSPHOSPHATE COMBINATION CATALYST | ANDERSON DEVELOPMENT COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046408-A1 | GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF | DAGLA, PHOSPHO1, DGKG | CYP3A4 956/4885LPAR3 1230/4885LPAR2 1651/4885 |
| US-20090203556-A1 | GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF | DAGLA, PHOSPHO1, DGKG | CYP3A4 956/4885LPAR3 1230/4885LPAR2 1651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.